Literature DB >> 26036222

Surgical intervention strategy for postoperative chylothorax after lung resection.

Shinsuke Uchida1, Kenji Suzuki2, Aritoshi Hattori1, Kazuya Takamochi1, Shiaki Oh1.   

Abstract

PURPOSE: The optimal surgical management of postoperative chylothorax has not been established. Thus, we evaluated the treatment strategy for postoperative chylothorax and identified associated predictors of surgical intervention.
METHODS: The subjects of this retrospective study were 50 patients who suffered postoperative chylothorax, representing 4 % of 1235 patients who underwent pulmonary resection between 2008 and 2012. The chylothorax patients were classified into two groups based on their postoperative management: a conservative group and a surgical group. The following parameters were investigated to establish the predictors of surgical intervention for chylothorax: mode of surgery, preoperative complications, intraoperative management, and postoperative clinical status.
RESULTS: Forty-one (82 %) patients were treated conservatively and 9 (18 %) underwent reoperation, as direct or concomitant ligation of the thoracic duct at the point of leakage. The frequency of postoperative chest tube drainage just after initial surgery was significantly greater in the surgical group than the conservative group before oral intake was restarted (448 ± 189 vs. 296 ± 117 ml/12 h, respectively; p = 0.003). Furthermore, it was a significant predictor of reoperation based on a multivariate analysis (p = 0.010).
CONCLUSIONS: The amount of chest tube drainage just after surgery and before oral intake was a useful predictor to help us decide on the need for early surgical intervention for postoperative chylothorax.

Entities:  

Keywords:  Chylothorax; Lung cancer surgery; Postoperative care; Surgery complications; Thoracic duct

Mesh:

Year:  2015        PMID: 26036222     DOI: 10.1007/s00595-015-1183-6

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  18 in total

1.  Chylothorax complicating pulmonary resection for lung cancer: effective management and pleurodesis.

Authors:  Hyun Jin Cho; Dong Kwan Kim; Geun Dong Lee; Hee Je Sim; Se Hoon Choi; Hyeong Ryul Kim; Yong-Hee Kim; Seung-Il Park
Journal:  Ann Thorac Surg       Date:  2013-12-21       Impact factor: 4.330

2.  Treatment of a persistent postoperative chylothorax with somatostatin.

Authors:  P C Rimensberger; B Müller-Schenker; A Kalangos; M Beghetti
Journal:  Ann Thorac Surg       Date:  1998-07       Impact factor: 4.330

3.  Management of chylothorax in adults: when is surgery indicated?

Authors:  H Zabeck; T Muley; H Dienemann; H Hoffmann
Journal:  Thorac Cardiovasc Surg       Date:  2011-03-21       Impact factor: 1.827

4.  Chylothorax: indications for surgery.

Authors:  J G Selle; W H Snyder; J T Schreiber
Journal:  Ann Surg       Date:  1973-02       Impact factor: 12.969

Review 5.  Early thoracic duct ligation for postoperative chylothorax.

Authors:  E M Sieczka; J C Harvey
Journal:  J Surg Oncol       Date:  1996-01       Impact factor: 3.454

6.  Conservative management of postoperative chylothorax using somatostatin.

Authors:  R F Kelly; S J Shumway
Journal:  Ann Thorac Surg       Date:  2000-06       Impact factor: 4.330

7.  Postoperative chylothorax.

Authors:  R J Cerfolio; M S Allen; C Deschamps; V F Trastek; P C Pairolero
Journal:  J Thorac Cardiovasc Surg       Date:  1996-11       Impact factor: 5.209

8.  Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer.

Authors:  Kimihiro Shimizu; Junji Yoshida; Mituyo Nishimura; Kazuya Takamochi; Rie Nakahara; Kanji Nagai
Journal:  J Thorac Cardiovasc Surg       Date:  2002-09       Impact factor: 5.209

9.  Low-fat diet management strategy for chylothorax after pulmonary resection and lymph node dissection for primary lung cancer.

Authors:  Teruhisa Takuwa; Junji Yoshida; Shotaro Ono; Tomoyuki Hishida; Mitsuyo Nishimura; Keiju Aokage; Kanji Nagai
Journal:  J Thorac Cardiovasc Surg       Date:  2013-06-12       Impact factor: 5.209

10.  Surgical management of chylothorax.

Authors:  S Paul; N K Altorki; J L Port; B M Stiles; P C Lee
Journal:  Thorac Cardiovasc Surg       Date:  2009-05-20       Impact factor: 1.827

View more
  5 in total

1.  Body surface area is a novel predictor for surgical complications following video-assisted thoracoscopic surgery for lung adenocarcinoma: a retrospective cohort study.

Authors:  Shuangjiang Li; Kun Zhou; Heng Du; Cheng Shen; Yongjiang Li; Guowei Che
Journal:  BMC Surg       Date:  2017-06-12       Impact factor: 2.102

2.  Body surface area as a novel risk factor for chylothorax complicating video-assisted thoracoscopic surgery lobectomy for non-small cell lung cancer.

Authors:  Shuangjiang Li; Yan Wang; Kun Zhou; Shan Cheng; Yanming Wu; Guowei Che
Journal:  Thorac Cancer       Date:  2018-10-16       Impact factor: 3.500

Review 3.  A review of the postoperative lymphatic leakage.

Authors:  Shulan Lv; Qing Wang; Wanqiu Zhao; Lu Han; Qi Wang; Nasra Batchu; Qurat Ulain; Junkai Zou; Chao Sun; Jiang Du; Qing Song; Qiling Li
Journal:  Oncotarget       Date:  2017-04-20

4.  Chylothorax after pulmonary resection and lymph node dissection for primary lung cancer; retrospective observational study.

Authors:  Yoshiyuki Yasuura; Hayato Konno; Takamitsu Hayakawa; Yukihiro Terada; Kiyomichi Mizuno; Hiroyuki Kayata; Hideaki Kojima; Tetsuya Mizuno; Mitsuhiro Isaka; Yasuhisa Ohde
Journal:  J Cardiothorac Surg       Date:  2022-01-22       Impact factor: 1.637

5.  New Combined Medical Treatment With Etilefrine and Octreotide for Chylothorax After Esophagectomy: A Case Report and Review of the Literature.

Authors:  Yu Ohkura; Masaki Ueno; Toshiro Iizuka; Shusuke Haruta; Tsuyoshi Tanaka; Harushi Udagawa
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.